Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase

Details for Australian Patent Application No. 2005286728 (hide)

Owner Xenon Pharmaceuticals Inc.

Inventors Fu, Jian-Min; Raina, Vandna; Liu, Shifeng; Seid Bagherzadeh, Mehran; Chakka, Nagasree; Zhang, Zaihui; Kodumuru, Vishnumurthy; Sun, Shaoyi; Kamboj, Rajender; Sviridov, Serguei; Hou, Duanjie; Chowdhury, Sultan

Agent Davies Collison Cave

Pub. Number AU-A-2005286728

PCT Pub. Number WO2006/034338

Priority 60/611,645 20.09.04 US

Filing date 20 September 2005

Wipo publication date 30 March 2006

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/034338 Priority application(s): WO2006/034338

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286729-Removing carbon dioxide from waste streams through co-generation of carbonate and/or bicarbonate minerals

2005286727-Carbazole and cyclopentaindole derivatives to treat infection with Hepatitis C virus